Filing Flows › Camp4 Therapeutics (CAMP) › Q2 2025
Camp4 Therapeutics (CAMP) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Camp4 Therapeutics (CAMP) reported revenue of $1.5M for the second quarter 2025 (Q2 2025) and +74% from the quarter before. Operating margin was -870.3%, net loss $12.6M (840.8% of revenue).
Camp4 Therapeutics, Q2 2025: revenue $1.5M, operating margin -870.3%, net loss $12.6M, operating cash flow −$10.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | +74% | — |
| Operating profit | −$13.0M | — | — |
| Net earnings | −$12.6M | — | — |
| Operating cash flow | −$10.3M | — | — |
What changed
Revenue was $1.5M in Q2 2025, up 74% from the previous quarter.
Operating costs exceeded revenue by $13.0M, an operating margin of -870.3%. The quarter ended with a net loss of $12.6M, wider than the previous quarter's $12.4M loss.
Operating cash flow was −$10.3M. Non-cash charges added back $430K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items added $812K.
Questions
What was Camp4 Therapeutics' revenue in the second quarter 2025?
Camp4 Therapeutics (CAMP) reported revenue of $1.5M for the second quarter 2025 (Q2 2025) and +74% from the quarter before.
Was Camp4 Therapeutics profitable in the second quarter 2025?
Operating loss was $13.0M (-870.3% of revenue) and net loss $12.6M.
Source: Camp4 Therapeutics 10-Q on SEC EDGAR.